Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis

Four oral penicillin V regimens were compared for the ability to prevent Streptococcus sanguis infection of experimentally induced valvular heart lesions in rabbits. Challenge doses of 10(4), 10(6), and 10(8) CFU of a penicillin-susceptible strain of S. sanguis were used in this study. Measured by recovery of test organisms from endocardial lesions, the lowest-concentration inoculum was infective for 53% of the recipients; the higher-concentration inocula were infective for all recipients. A single-oral-dose penicillin V regimen (36 mg/kg of body weight) prevented endocarditis when rabbits were challenged with 10(4) CFU, but protection diminished with increasing inoculum concentrations. In contrast, addition of a second penicillin V dose (18 mg/kg of body weight) administered with a 7-h interval between doses achieved fully effective prophylaxis against even the highest inoculum tested (10(8) CFU). A repeated set of experiments in which half the dose of penicillin V was administered showed significantly reduced protection against S. sanguis endocarditis.

[1]  J. Garau,et al.  Comparative capacity of orally administered amoxicillin and parenterally administered penicillin-streptomycin to protect rabbits against experimentally induced streptococcal endocarditis , 1986, Antimicrobial Agents and Chemotherapy.

[2]  A. Bisno,et al.  Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. , 1984, Circulation.

[3]  D. Durack,et al.  Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis. , 1983, The Journal of antimicrobial chemotherapy.

[4]  P. Francioli,et al.  Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. , 1983, The Journal of infectious diseases.

[5]  P. Francioli,et al.  Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. , 1982, The Journal of infectious diseases.

[6]  D. Shanson,et al.  Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia. , 1978, The Journal of antimicrobial chemotherapy.

[7]  W. Johnson,et al.  Penicillin-sensitive streptococcal endocarditis. In-vitro and clinical observations on penicillin-streptomycin therapy. , 1974, Annals of internal medicine.

[8]  D. Durack,et al.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. , 1973, The Journal of clinical investigation.

[9]  D. Durack,et al.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. , 1972, British journal of experimental pathology.

[10]  B. Perlman,et al.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. , 1971, The Yale journal of biology and medicine.

[11]  E. Benner,et al.  Simplified, accurate method for antibiotic assay of clinical specimens. , 1966, Applied microbiology.

[12]  P. Francioli,et al.  Successful prophylaxis of experimental streptococcal endocarditis with single doses of sublethal concentrations of penicillin. , 1985, The Journal of antimicrobial chemotherapy.

[13]  W. Craig,et al.  Postantibiotic suppression of bacterial growth. , 1981, Reviews of infectious diseases.